IRB Study Number 24-028
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Heart and Vascular Institute
Description
The study seeks to evaluate the use of magnetocardiography (MCG) to identify coronary ischemia, a condition where blood flow is reduced in the heart muscle and compare results to a cardiac PET scan. The diagnostic capabilities of the magnetocardiography scanner being evaluated is called CardioFlux. CardioFlux has been cleared by the FDA for use as a general tool which non-invasively measures and displays the magnetic signals produced by the electric currents of the heart. Study participation involves a 15 minute scan and a short survey.
Inclusion Criteria
Willing to provide written informed consent.
Male or female, aged 40 and up (inclusive) at the time of enrollment
Clinical suspicion of myocardial ischemia that clinician desired cardiac PET
Exclusion Criteria
Participants unable to fit into device
Patients unable to lie supine for 5 minutes
Ongoing/currently in atrial fibrillation or atrial flutter at the time of enrollment
